Tokyo, Japan

Tatsuki Wakayama

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Inpex Corporation, Nagaoka University of Technology. Active years: 2018.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2018

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Tatsuki Wakayama

Introduction

Tatsuki Wakayama is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of biotechnology, particularly in the development of cellulase-producing microorganisms. His work focuses on enhancing the production of cello-oligosaccharides, which are valuable in various industrial applications.

Latest Patents

Wakayama holds a patent for a mutant of a cellulase-producing microorganism, which is capable of preferentially producing cello-oligosaccharides. The patent details a method for producing cellulase and a method for producing cello-oligosaccharides using this cellulase. The invention specifically relates to a mutant microorganism in which cellobiohydrolase and β-glucosidase genes are disrupted. This innovation aims to improve the efficiency of enzymolysis of cellulosic materials.

Career Highlights

Throughout his career, Tatsuki Wakayama has been associated with prestigious institutions such as Nagaoka University of Technology and Inpex Corporation. His work in these organizations has allowed him to advance his research and contribute to the scientific community.

Collaborations

Wakayama has collaborated with notable colleagues, including Wataru Ogasawara and Takashi Yamaguchi. These partnerships have facilitated the exchange of ideas and expertise, further enhancing the impact of his inventions.

Conclusion

Tatsuki Wakayama's innovative work in the field of biotechnology exemplifies the importance of research in developing efficient methods for producing valuable compounds. His contributions continue to influence the industry and pave the way for future advancements.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…